Zobrazeno 1 - 10 of 62 pro vyhledávání: '"Ben F. M. Wijnen"'
1
Akademický článek
Exercise enhances: study protocol of a randomized controlled trial on aerobic exercise as depression treatment augmentation
Autor: Michèle Schmitter, Jan Spijker, Filip Smit, Indira Tendolkar, Anne-Marie Derksen, Peter Oostelbos, Ben F. M. Wijnen, Tessa J. van Doesum, Jasper A. J. Smits, Janna N. Vrijsen
Publikováno v: BMC Psychiatry, Vol 20, Iss 1, Pp 1-11 (2020)
Abstract Background Major depressive disorder (MDD) is a considerable public health concern. In spite of evidence-based treatments for MDD, many patients do not improve and relapse is common. Therefore, improving treatment outcomes is much needed and
Externí odkaz: https://doaj.org/article/e2167cd7fd9c4972bfce5d81e9b22c6b
Zobrazit plný text záznamu
2
Akademický článek
Towards community-based and recovery-oriented care for severe mental disorders in Southern and Eastern Europe: aims and design of a multi-country implementation and evaluation study (RECOVER-E)
Autor: Laura Shields-Zeeman, Ionela Petrea, Filip Smit, Bethany Hipple Walters, Jovo Dedovic, Martina Rojnic Kuzman, Vladimir Nakov, Raluca Nica, Antoni Novotni, Catharina Roth, Aleksandar Tomcuk, Ben F. M. Wijnen, Michel Wensing
Publikováno v: International Journal of Mental Health Systems, Vol 14, Iss 1, Pp 1-14 (2020)
Abstract Background Substantial strides have been made around the world in reforming mental health systems by shifting away from institutional care towards community-based services. Despite an extensive evidence base on what constitutes effective car
Externí odkaz: https://doaj.org/article/75cac83082bd436998a8c73a6ccd71c9
Zobrazit plný text záznamu
3
Akademický článek
Mapping of the World Health Organization's Disability Assessment Schedule 2.0 to disability weights using the Multi‐Country Survey Study on Health and Responsiveness
Autor: Joran Lokkerbol, Ben F. M. Wijnen, Somnath Chatterji, Ronald C. Kessler, Dan Chisholm
Publikováno v: International Journal of Methods in Psychiatric Research, Vol 30, Iss 3, Pp n/a-n/a (2021)
Abstract Objectives To develop and test an internationally applicable mapping function for converting WHODAS‐2.0 scores to disability weights, thereby enabling WHODAS‐2.0 to be used in cost‐utility analyses and sectoral decision‐making. Metho
Externí odkaz: https://doaj.org/article/bfb8688278ad491481164357f77a3d1e
Zobrazit plný text záznamu
4
Akademický článek
Cost-effectiveness, cost-utility and the budget impact of antidepressants versus preventive cognitive therapy with or without tapering of antidepressants
Autor: Nicola S. Klein, Ben F. M. Wijnen, Joran Lokkerbol, Erik Buskens, Hermien J. Elgersma, Gerard D. van Rijsbergen, Christien Slofstra, Johan Ormel, Jack Dekker, Peter J. de Jong, Willem A. Nolen, Aart H. Schene, Steven D. Hollon, Huibert Burger, Claudi L. H. Bockting
Publikováno v: BJPsych Open, Vol 5 (2019)
BackgroundAs depression has a recurrent course, relapse and recurrence prevention is essential.AimsIn our randomised controlled trial (registered with the Nederlands trial register, identifier: NTR1907), we found that adding preventive cognitive ther
Externí odkaz: https://doaj.org/article/9e2eb99ea6a04c61b133640913768230
Zobrazit plný text záznamu
5
Mogamulizumab for Previously Treated Mycosis Fungoides and Sézary Syndrome: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Autor: Steven Duffy, Manuela A. Joore, Nigel Armstrong, Annette Chalker, Sabine Grimm, Robert Wolff, Isabel Syndikus, Mickaël Hiligsmann, Willem J.A. Witlox, Jos Kleijnen, Charlotte Ahmadu, Ben F. M. Wijnen, Steve Ryder
Publikováno v: Pharmacoeconomics. 40(5):509-518
The National Institute for Health and Care Excellence (NICE) invited the manufacturer (Kyowa Kirin) of mogamulizumab (Poteligeo(R)), as part of the single technology appraisal process, to submit evidence for its clinical and cost-effectiveness for pr
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc1ab53ca166964105141105c17b0b0b
https://doi.org/10.1007/s40273-021-01098-3
Zobrazit plný text záznamu
6
ZMILE, a multicomponent self-management intervention for adults with epilepsy
Autor: Ingeborg M. van der Putten, Caroline M. van Heugten, Silvia M. A. A. Evers, Hoi Yau Chan, Ben F. M. Wijnen, L. Leenen, M.H. Majoie
Publikováno v: Clinical Rehabilitation, 35(5), 629-638. SAGE Publications Ltd
Clinical Rehabilitation
Objective: In this paper, we aim to provide a comprehensive description of the multicomponent self-management intervention for adults with epilepsy, ZMILE. Rationale or theory: Acquiring self-management skills has been shown to play a vital role in e
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e03bd2328e19e678a00f6d13f61d875
https://doi.org/10.1177/0269215520975327
Zobrazit plný text záznamu
7
Design of a health-economic Markov model to assess cost-effectiveness and budget impact of the prevention and treatment of depressive disorder
Autor: Joran Lokkerbol, Henricus G. Ruhé, Filip Smit, Arshia Morad, Pim Cuijpers, Ben F. M. Wijnen, Marrit K. de Boer, Jan Spijker, Robert A. Schoevers
Publikováno v: Expert Review of Pharmacoeconomics and Outcomes Research, 21, 1031-1042
Expert Review of Pharmacoeconomics and Outcomes Research, 21(5), 1031-1042. Expert Reviews Ltd.
Expert Review of Pharmacoeconomics & Outcomes Research, 21(5), 1031-1042. Routledge/Taylor & Francis Group
Expert review of pharmacoeconomics & outcomes research, 21(5), 1031-1042. Taylor & Francis Group
Expert review of pharmacoeconomics & outcomes research, 21(5), 1031-1042. Taylor and Francis Ltd.
Expert Review of Pharmacoeconomics and Outcomes Research, 21, 5, pp. 1031-1042
Lokkerbol, J, Wijnen, B, Ruhe, H G, Spijker, J, Morad, A, Schoevers, R, de Boer, M K, Cuijpers, P & Smit, F 2021, ' Design of a health-economic Markov model to assess cost-effectiveness and budget impact of the prevention and treatment of depressive disorder ', Expert Review of Pharmacoeconomics and Outcomes Research, vol. 21, no. 5, pp. 1031-1042 . https://doi.org/10.1080/14737167.2021.1844566
Expert Review of Pharmacoeconomics & Outcomes Research
article-version (VoR) Version of Record
Lokkerbol, J, Wijnen, B, Ruhe, H G, Spijker, J, Morad, A, Schoevers, R, de Boer, M K, Cuijpers, P & Smit, F 2021, ' Design of a health-economic Markov model to assess cost-effectiveness and budget impact of the prevention and treatment of depressive disorder ', Expert review of pharmacoeconomics & outcomes research, vol. 21, no. 5, pp. 1031-1042 . https://doi.org/10.1080/14737167.2021.1844566
Contains fulltext : 225612.pdf (Publisher’s version ) (Open Access) Background/objective: To describe the design of 'DepMod', a health-economic Markov model for assessing cost-effectiveness and budget impact of user-defined preventive interventions
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ae2b368a4a5c204e4474b0bd3c210ab
https://research.vu.nl/en/publications/0964afbe-9f4a-4d96-80b3-951684d583fa
Zobrazit plný text záznamu
8
Economic evaluation of a home-based programme to reduce concerns about falls in frail, independently-living older people
Autor: Silvia M. A. A. Evers, Jolanda C. M. van Haastregt, Tanja A. C. Dorresteijn, Gertrudis I. J. M. Kempen, G. A. Rixt Zijlstra, Ben F. M. Wijnen
Publikováno v: Expert Review of Pharmacoeconomics & Outcomes Research, 20(6), 641-651. Routledge/Taylor & Francis Group
Background: Concerns about falls, or fear of falling, are frequently reported by older people and can have serious consequences. Aim of this study was to evaluate the cost-effectiveness of a home-based, cognitive behavioral programme for independentl
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45dfa352f8bfbcaf0de152b4666b7b4d
https://cris.maastrichtuniversity.nl/en/publications/c8b3f527-031a-4fca-a69d-3c682181aead
Zobrazit plný text záznamu
9
Cannabidiol for Adjuvant Treatment of Seizures Associated with Lennox-Gastaut Syndrome and Dravet Syndrome
Autor: Marie Westwood, Willem J.A. Witlox, Debra Fayter, Ben F. M. Wijnen, Kate Misso, Steve Ryder, Titas Buksnys, Nigel Armstrong, Gill Worthy, Bram Ramaekers, Manuela A. Joore, Sabine Grimm, Jos Kleijnen
Publikováno v: Pharmacoeconomics. 38(10):1043-1053
GW Research Ltd. provided two separate, but similar, submissions to the National Institute for Health and Care Excellence (NICE) on the clinical and cost-effectiveness of cannabidiol (CBD) 10 mg/kg/day, trade name Epidyolex(R), for the adjunctive tre
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d167585eeb19c3050f3d481cb607441
https://doi.org/10.1007/s40273-020-00932-4
Zobrazit plný text záznamu
10
Designing and Testing of a Health-Economic Markov Model for Prevention and Treatment of Early Psychosis
Autor: Mark van der Gaag, Mickaël Hiligsmann, Wim Veling, Frederick W. Thielen, Steef Konings, Talitha L Feenstra, Joran Lokkerbol, Filip Smit, Silvia M. A. A. Evers, Helga K. Ising, Ben F. M. Wijnen, Lieuwe de Haan
Publikováno v: Expert review of pharmacoeconomics & outcomes research. Taylor & Francis Ltd
Expert Review of Pharmacoeconomics & Outcomes Research, 20(3), 269-279. Routledge/Taylor & Francis Group
Wijnen, B F M, Thielen, F W, Konings, S, Feenstra, T, Van Der Gaag, M, Veling, W, De Haan, L, Ising, H, Hiligsmann, M, Evers, S M A A, Smit, F & Lokkerbol, J 2020, ' Designing and Testing of a Health-Economic Markov Model for Prevention and Treatment of Early Psychosis ', Expert Review of Pharmacoeconomics and Outcomes Research, vol. 20, no. 3, pp. 269-279 . https://doi.org/10.1080/14737167.2019.1632194
Expert Review of Pharmacoeconomics and Outcomes Research, 20(3), 269-279. Expert Reviews Ltd.
Wijnen, B F M, Thielen, F W, Konings, S, Feenstra, T, van der Gaag, M, Veling, W, de Haan, L, Ising, H, Hiligsmann, M, Evers, S M A A, Smit, F & Lokkerbol, J 2020, ' Designing and Testing of a Health-Economic Markov Model for Prevention and Treatment of Early Psychosis ', Expert review of pharmacoeconomics & outcomes research, vol. 20, no. 3, pp. 269-279 . https://doi.org/10.1080/14737167.2019.1632194
Expert review of pharmacoeconomics & outcomes research. Taylor & Francis Group
Expert review of pharmacoeconomics & outcomes research, 20(3), 269-279. Taylor and Francis Ltd.
BACKGROUND: This study aims to report on the design of a model to determine the cost-effectiveness of prevention and treatment of early psychosis (PsyMod) and to estimate ten-year cost-effectiveness and budget impact of interventions targeting indivi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02debc7401b9508310ef1c0c869f7219
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85068155768&origin=inward
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje